LXRX
Lexicon Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.69
-0.03 ▼ -1.74%
🌙 3월 13일 7:49 PM ET (한국 3/14 08:49)
$1.69
+0.00 -0.30%
| Index | - | P/E | - | EPS (ttm) | -0.14 | Insider Own | 57.57% | Shs Outstand | 0.36B | Perf Week | -1.17% |
| Market Cap | 0.72B | Forward P/E | - | EPS next Y | -16.35% | Insider Trans | 0.85% | Shs Float | 0.18B | Perf Month | 23.36% |
| Enterprise Value | 0.68B | PEG | - | EPS next Q | -0.03 | Inst Own | 21.52% | Short Float | 12.87% | Perf Quarter | 28.03% |
| Income | -0.05B | P/S | 14.38 | EPS this Y | -26.49% | Inst Trans | -29.7% | Short Ratio | 8.32 | Perf Half Y | 52.25% |
| Sales | 0.05B | P/B | 5.71 | EPS next 5Y | 8.44% | ROA | -20.83% | Short Interest | 23.14M | Perf YTD | 46.96% |
| Book/sh | 0.3 | P/C | 7.44 | EPS past 3/5Y | 39.13% 23.47% | ROE | -39.72% | 52W High | -7.65% ($1.83) | Perf Year | 373.39% |
| Cash/sh | 0.23 | P/FCF | - | Sales past 3/5Y | 610.25% 15.72% | ROIC | -30.78% | 52W Low | 428.13% ($0.32) | Perf 3Y | -26.84% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 78.37% | Gross Margin | 98.2% | Volatility(W/M) | 7.21% 7.79% | Perf 5Y | -75.4% |
| Dividend TTM | - | EV/Sales | 13.7 | Sales Y/Y TTM | 60.24% | Oper. Margin | -98.21% | ATR (14) | 0.13 | Perf 10Y | -84.96% |
| Dividend Ex-Date | - | Quick Ratio | 4.87 | EPS Q/Q | 54.28% | Profit Margin | -101.08% | RSI (14) | 63.04 | Recom | 1.8 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.88 | Sales Q/Q | -79.31% | SMA20 | 8.96% ($1.55) | Beta | 0.94 | Target Price | $3.36 |
| Payout | - | Debt/Eq | 0.58 | Earnings | 3000000 | SMA50 | 19.88% ($1.41) | Rel Volume | 0.81 | Prev Close | $1.72 |
| Employees | 81 | LT Debt/Eq | 0.52 | EPS/Sales Surpr. | 42.03% 74.85% | SMA200 | 36.97% ($1.23) | Avg Volume(3M) | 2.78M | Price | $1.69 |
| IPO | 2000/4/7 | Option/Short | Yes/Yes | Trades | 4514 | Volume | 2,245,545 | Change | -1.74% |
뉴스 로딩 중...